Robotic arm-assisted medial compartment knee arthroplasty is a cost-effective intervention at ten-year follow-up
- PMID: 39740684
- DOI: 10.1302/0301-620X.107B1.BJJ-2024-0245.R2
Robotic arm-assisted medial compartment knee arthroplasty is a cost-effective intervention at ten-year follow-up
Abstract
Aims: The aim of this study was to perform an incremental cost-utility analysis and assess the impact of differential costs and case volume on the cost-effectiveness of robotic arm-assisted medial unicompartmental knee arthroplasty (rUKA) compared to manual (mUKA).
Methods: Ten-year follow-up of patients who were randomized to rUKA (n = 64) or mUKA (n = 65) was performed. Patients completed the EuroQol five-dimension health questionnaire preoperatively, at three months, and one, two, five, and ten years postoperatively, which was used to calculate quality-adjusted life years (QALY) gained and the incremental cost-effectiveness ratio (ICER). Costs for the index and additional surgery and healthcare costs were calculated.
Results: mUKA had a lower survival for reintervention (84.8% (95% CI 76.2 to 93.4); p = 0.001), all-cause revision (88.9% (95% CI 81.3 to 96.5); p = 0.007) and aseptic revision (91.9% (95% CI 85.1 to 98.7); p = 0.023) when compared to the rUKA group at ten years, which was 100%. The rUKA group had a greater QALY gain per patient (mean difference 0.186; p = 0.651). Overall rUKA was the dominant intervention, being cost-saving and more effective with a greater health-related quality of life gain. On removal of infected reinterventions (n = 2), the ICER was £757 (not discounted) and £481 (discounted). When including all reintervention costs, rUKA was cost-saving when more than 100 robotic cases were performed per year. When removing the infected cases, rUKA was cost-saving when undertaking more than 800 robotic cases per year.
Conclusion: rUKA had lower reintervention and revision risks at ten years, which was cost-saving and associated with a greater QALY gain, and was the dominant procedure. When removing the cost of infection, which could be a random event, rUKA was a cost-effective intervention with an ICER (£757) which was lower than the willingness-to-pay threshold (£20,000).
© 2025 The British Editorial Society of Bone & Joint Surgery.
Conflict of interest statement
None declared.
References
-
- Sabah SA , Knight R , Alvand A , Beard DJ , Price AJ . Early patient-reported outcomes from primary hip and knee arthroplasty have improved over the past seven years: an analysis of the NHS PROMs dataset . Bone Joint J . 2022 ; 104-B ( 6 ): 687 – 695 . 10.1302/0301-620X.104B6.BJJ-2021-1577.R1 35638211
-
- Chen B , Clement ND , MacDonald D , Hamilton DF , Gaston P . Cost-utility analysis of total knee arthroplasty using 10-year data from a randomised controlled trial: implant design influences quality-adjusted life year gain . Knee . 2023 ; 44 : 79 – 88 . 10.1016/j.knee.2023.07.002 37542953
-
- Bell SW , Anthony I , Jones B , MacLean A , Rowe P , Blyth M . Improved accuracy of component positioning with robotic-assisted unicompartmental knee arthroplasty . J Bone Joint Surg Am . 2016 ; 98-A ( 8 ): 627 – 635 . 10.2106/JBJS.15.00664 27098321
-
- Zhang J , Ndou WS , Ng N , et al. Robotic-arm assisted total knee arthroplasty is associated with improved accuracy and patient reported outcomes: a systematic review and meta-analysis . Knee Surg Sports Traumatol Arthrosc . 2022 ; 30 ( 8 ): 2677 – 2695 . 10.1007/s00167-021-06464-4 33547914
-
- Zhang J , Ng N , Scott CEH , et al. Robotic arm-assisted versus manual unicompartmental knee arthroplasty: a systematic review and meta-analysis of the MAKO robotic system . Bone Joint J . 2022 ; 104-B ( 5 ): 541 – 548 . 10.1302/0301-620X.104B5.BJJ-2021-1506.R1 35491572
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
